Effect of nintedanib on lung function in patients with systemic sclerosis-associated interstitial lung disease: further analyses of a randomized, double-blind, placebo-controlled trial - Maher, Toby M.; Mayes, Maureen D.; Kreuter, Michael; Volkmann, Elizabeth R.; Aringer, Martin; Castellvi, Ivan; Cutolo, Maurizio; Stock, Christian; Schoof, Nils; Alves, Margarida; Raghu, Ganesh (Arthritis & rheumatology, 2021)
First published: 03 November 2020